Ferroptosis and its modulation by autophagy in light of the pathogenesis of lysosomal storage diseases

K Pierzynowska, E Rintz, L Gaffke, G Węgrzyn - Cells, 2021 - mdpi.com
Ferroptosis is one of the recently described types of cell death which is dependent on many
factors, including the accumulation of iron and lipid peroxidation. Its induction requires …

Glycoengineering Chinese hamster ovary cells: a short history

R Donini, SM Haslam… - Biochemical Society …, 2021 - portlandpress.com
Biotherapeutic glycoproteins have revolutionised the field of pharmaceuticals, with new
discoveries and continuous improvements underpinning the rapid growth of this industry. N …

The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants

R Sánchez, T Ripoll-Vera, M López-Mendoza… - Orphanet journal of rare …, 2023 - Springer
Background Fabry disease (FD) is an X-linked condition caused by variants in the GLA
gene. Since females have two X chromosomes, they were historically thought to be carriers …

Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?

G Bertoldi, I Caputo, G Driussi, LF Stefanelli… - Journal of Clinical …, 2023 - mdpi.com
Fabry disease is a rare X-linked disease characterized by deficient expression and activity of
alpha-galactosidase A (α-GalA) with consequent lysosomal accumulation of …

[HTML][HTML] 2021 TSOC expert consensus on the clinical features, diagnosis, and clinical management of cardiac manifestations of Fabry disease

CL Hung, YW Wu, CC Lin, CH Lai… - Acta Cardiologica …, 2021 - ncbi.nlm.nih.gov
Fabry disease (FD) is an X-linked, rare inherited lysosomal storage disease caused by α-
galactosidase A gene variants resulting in deficient or undetectable α-galactosidase A …

Fabry disease and kidney involvement: starting from childhood to understand the future

R Chimenz, V Chirico, C Cuppari, G Ceravolo… - Pediatric …, 2022 - Springer
The accumulation of globotriaosylceramide (Gb-3) in multiple organs, such as the heart,
kidney, and nervous system, due to mutations in the galactosidase alpha (GLA) gene …

Outcomes and management of kidney transplant recipients with Fabry disease: a review

B Yu, MG Atta, DC Brennan, S Kant - Journal of Nephrology, 2024 - Springer
Fabry disease is an X-linked inheritable lysosomal storage disease caused by various
mutations of the galactosidase α gene resulting in α-galactosidase deficiency. Chronic …

Newborn genetic screening for Fabry disease: Insights from a retrospective analysis in Nanjing, China

Y Sun, XW Guan, YY Wang, DY Hong, ZL Zhang… - Clinica Chimica …, 2024 - Elsevier
Fabry disease (FD), an X-linked disorder resulting from dysfunction of α-galactosidase A,
can result in significant complications. Early intervention yields better outcomes, but …

[HTML][HTML] Antigen-display exosomes provide adjuvant-free protection against SARS-CoV-2 disease at nanogram levels of spike protein

C Guo, J Sachithanandham, W Zhong, M Craney… - bioRxiv, 2024 - ncbi.nlm.nih.gov
As the only bionormal nanovesicle, exosomes have high potential as a nanovesicle for
delivering vaccines and therapeutics. We show here that the loading of type-1 membrane …

Biopharmaceutical applications of α‐galactosidases

GS Anisha - Biotechnology and applied biochemistry, 2023 - Wiley Online Library
Abstract α‐Galactosidases are exoglycosidases that are active on galactose‐containing side
chains in oligosaccharides, polysaccharides, glycolipids, and glycoproteins. α …